Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quinazolinone cholecystokinin (CCK)-B antagonists decrease midbrain dopamine unit activity

K Rasmussen1, M J Yu, J F Czachura

  • 1Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285.

Synapse (New York, N.Y.)
|August 1, 1994
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat.

Naunyn-Schmiedeberg's archives of pharmacology·2000
Same author

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

The Journal of pharmacology and experimental therapeutics·2000
Same author

External quality assessment of methylmalonic acid and total homocysteine.

Clinical chemistry·1999
Same author

Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1999
Same author

Coenzyme Q10 treatment in serious heart failure.

BioFactors (Oxford, England)·1999
Same author

[Hereditary neuropathy with liability to pressure palsies].

Ugeskrift for laeger·1999